Johnson & Johnson Shares Skirt a 52-Week Low. Here’s What’s Ailing Healthcare.

Shares of Johnson & Johnson approached a 52-week low Tuesday, just over a week after the drugmaker reported better than expected third-quarter financial results and raised its forecast for full-year earnings. Johnson & Johnson (ticker: JNJ) has entirely given up the gains it clocked in the first half of the year, when shares climbed from $150.11 in late March to $174.01 in late August. More than one malady has struck the healthcare sector, and there’s no panacea in sight.